Companies:

Articles:

Neurotech International Limited (ASX: NTI)

Company news

Cover Image for Neurotech International admits final patient for NTI164 Phase II/III trial to treat autism

Neurotech International admits final patient for NTI164 Phase II/III trial to treat autism

April 10, 2024

Cover Image for Australian biotech sector tipped for strong growth

Australian biotech sector tipped for strong growth

March 19, 2024

Cover Image for Neurotech International extends NTI164 Rett Syndrome trial to 52 weeks

Neurotech International extends NTI164 Rett Syndrome trial to 52 weeks

March 13, 2024

Cover Image for Neurotech International announces strong results from NTI164 PANDAS/PANS trial extension

Neurotech International announces strong results from NTI164 PANDAS/PANS trial extension

February 21, 2024